Improved asthma outcomes in a high-morbidity pediatric population: results of an emergency department-based randomized clinical trial

To determine if an emergency department-based asthma follow-up clinic could improve outcomes within a high-morbidity pediatric population. Prospective, randomized clinical trial with 6 months of follow-up. Emergency department of an urban pediatric medical center. Convenience sample of 488 patients...

Full description

Saved in:
Bibliographic Details
Published inArchives of pediatrics & adolescent medicine Vol. 160; no. 5; p. 535
Main Authors Teach, Stephen J, Crain, Ellen F, Quint, Deborah M, Hylan, Michelle L, Joseph, Jill G
Format Journal Article
LanguageEnglish
Published United States 01.05.2006
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To determine if an emergency department-based asthma follow-up clinic could improve outcomes within a high-morbidity pediatric population. Prospective, randomized clinical trial with 6 months of follow-up. Emergency department of an urban pediatric medical center. Convenience sample of 488 patients aged 12 months to 17 years, inclusive, with prior physician-diagnosed asthma and 1 or more other unscheduled visits in the previous 6 months and/or 1 or more hospitalizations in the prior 12 months. Single follow-up clinic visit focusing on 3 domains: asthma self-monitoring and management, environmental modification and trigger control, and linkages and referrals to ongoing care. The primary outcome measure was unscheduled visits for acute asthma care. Secondary outcomes included compliance with a medical plan and asthma quality of life. Analysis was by intention to treat with adjustment for baseline differences. Of those randomized to the clinic visit, 172 (70.5%) of 244 attended. The intervention group had significantly fewer mean unscheduled visits for asthma care during follow-up (1.39 vs 2.34; relative risk [RR] = 0.60 [95% confidence interval (CI), 0.46-0.77]). At 6 months, significantly more patients in the intervention group reported use of inhaled corticosteroids in the prior 2 days (49.3% vs 26.5%; RR = 2.03 [95% CI, 1.57-2.62]), no limitation in daytime quality of life (43.8% vs 34.4%; RR = 1.36 [95% CI, 1.06-1.73]), and no functional limitations in quality of life (49.8% vs 40.8%; RR = 1.33 [95% CI, 1.08-1.63]). Attendance in the follow-up clinic was high. The intervention decreased subsequent unscheduled health care use while improving compliance and quality of life.
ISSN:1072-4710
DOI:10.1001/archpedi.160.5.535